Efficacy of Pulsed Inhaled Nitric OXide (iNO) in adults with asymptomatic or mildly symptomatic COVID patients without co-morbidities (EPINOX study). A single centre, academic, prospective, case control, non-randomized, open labelled, interventional, comparative study - EPINOX

Sir h n Reliance Foundation hospital and research centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Adults, 18 â?? 50 years(account for 60% of cases in India as on May 6, 2021), with positive rtPCR and consenting to the study within 48 hours of diagnosis, already admitted or willing to get admitted to the COVID facility at SevenHills Hospital, managed by Sir H N Reliance Foundation Hospital, with asymptomatic or mildly symptomatic symptoms.

•A.Comorbid factors:
•2.Hypertension or hypotension
•3.Diabetes Mellitus
•4.Renal injury or failure
•5.Known abnormal Haemoglobinopathies
•6.Known clinically significant Pulmonary Arterial Hypertension
•7.Known congenital heart disease operated or otherwise
•8.Heart Failure (LVF <40%)
•B.Other factors:
•1.Additional treatment with Steroids, Tocilizumab, Plasma therapy.
•2.Requiring supplemental oxygen to maintain saturations > 93%
•3.Needing intubation and mechanical ventilation
•4.Past history of documented COVID-19 infection
•5.Completed COVID vaccination.
•6.Pregnant women, confirmed or suspected
•7.Mentally or neurologically disabled patients who are considered not fit to
•consent to their participation in the study
•8.Current smoker - Current smokerâ?? is someone who has smoked greater than 100
•cigarettes in their lifetime and has smoked in the last 28 days.

发起方

Sir h n Reliance Foundation hospital and research centre